Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Fanciulli

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Molecular & Cellular Oncology|June 17, 2016
AATF: A new actor in the complex world of mTORMaurizio Fanciulli
Frontiers in Genetics|April 28, 2015
Discovering Che-1/AATF: a new attractive target for cancer therapySimona Iezzi, Maurizio Fanciulli
Journal of Experimental & Clinical Cancer Research : CR|January 15, 2017
Deptor: not only a mTOR inhibitorValeria Catena, Maurizio Fanciulli
Cell Cycle (Georgetown, Tex.)|March 23, 2007
Che-1: a new effector of checkpoints signalingAristide Floridi, Maurizio Fanciulli
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2015
Application of RNA-Seq Technology in Cancer ChemopreventionFrauke Goeman, Maurizio Fanciulli
Cell Division|July 20, 2007
The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage responseClaudio Passananti, Maurizio Fanciulli
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|August 24, 2007
Che-1/AATF, a multivalent adaptor connecting transcriptional regulation, checkpoint control, and apoptosisClaudio Passananti, Aristide Floridi, Maurizio Fanciulli
Frontiers in Oncology|February 26, 2016
Che-1/AATF: A Critical Cofactor for Both Wild-Type- and Mutant-p53 ProteinsTiziana Bruno, Simona Iezzi, Maurizio Fanciulli
Gene|November 26, 2003
Genomic structure and transcriptional regulation of Che-1, a novel partner of RbLucia Monaco, Claudio Passananti, Maurizio Fanciulli
Cancers|March 1, 2019
Reverse Engineering Cancer: Inferring Transcriptional Gene Signatures from Copy Number Aberrations with ICAroDavide Angeli, Maurizio Fanciulli, Matteo Pallocca
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Molecular & Cellular Oncology|June 17, 2016
AATF: A new actor in the complex world of mTORMaurizio Fanciulli
Frontiers in Genetics|April 28, 2015
Discovering Che-1/AATF: a new attractive target for cancer therapySimona Iezzi, Maurizio Fanciulli
Journal of Experimental & Clinical Cancer Research : CR|January 15, 2017
Deptor: not only a mTOR inhibitorValeria Catena, Maurizio Fanciulli
Cell Cycle (Georgetown, Tex.)|March 23, 2007
Che-1: a new effector of checkpoints signalingAristide Floridi, Maurizio Fanciulli
Methods in Molecular Biology (Clifton, N.J.)|November 27, 2015
Application of RNA-Seq Technology in Cancer ChemopreventionFrauke Goeman, Maurizio Fanciulli
Cell Division|July 20, 2007
The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage responseClaudio Passananti, Maurizio Fanciulli
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|August 24, 2007
Che-1/AATF, a multivalent adaptor connecting transcriptional regulation, checkpoint control, and apoptosisClaudio Passananti, Aristide Floridi, Maurizio Fanciulli
Frontiers in Oncology|February 26, 2016
Che-1/AATF: A Critical Cofactor for Both Wild-Type- and Mutant-p53 ProteinsTiziana Bruno, Simona Iezzi, Maurizio Fanciulli
Gene|November 26, 2003
Genomic structure and transcriptional regulation of Che-1, a novel partner of RbLucia Monaco, Claudio Passananti, Maurizio Fanciulli
Cancers|March 1, 2019
Reverse Engineering Cancer: Inferring Transcriptional Gene Signatures from Copy Number Aberrations with ICAroDavide Angeli, Maurizio Fanciulli, Matteo Pallocca
Pageof 13